Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1991 | 1 |
2005 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
J Oncol Pharm Pract. 2005 Mar;11(1):13-9. doi: 10.1191/1078155205jp142oa.
J Oncol Pharm Pract. 2005.
PMID: 16460599
Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
Den Brok MW, Nuijen B, Kettenes-Van Den Bosch JJ, Van Steenbergen MJ, Buluran JN, Harvey MD, Grieshaber CK, Beijnen JH.
Den Brok MW, et al. Among authors: buluran jn.
PDA J Pharm Sci Technol. 2005 Sep-Oct;59(5):285-97.
PDA J Pharm Sci Technol. 2005.
PMID: 16316064
Item in Clipboard
Attenuation of contraction of isolated canine coronary arteries by enflurane and halothane.
Blaise GA, Hughes JM, Sill JC, Buluran JN, Caille G.
Blaise GA, et al. Among authors: buluran jn.
Can J Anaesth. 1991 Jan;38(1):111-5. doi: 10.1007/BF03009173.
Can J Anaesth. 1991.
PMID: 1846568
Item in Clipboard
Cite
Cite